Publication Cover
Child Neuropsychology
A Journal on Normal and Abnormal Development in Childhood and Adolescence
Volume 17, 2011 - Issue 2
208
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Executive Strategic Processing During Verbal Fluency Performance in Children with Phenylketonuria

, , &
Pages 105-117 | Received 12 Feb 2010, Accepted 12 Sep 2010, Published online: 07 Dec 2010
 

Abstract

In the current study, we examined a specific aspect of executive abilities, strategic processing, in 32 children with early-treated phenylketonuria (PKU) and 41 typically-developing control children. To do so, clustering and switching were assessed during semantic (animal, food/drink) and phonemic (S, F) fluency tasks. Specifically, number of words generated, number of subcategory clusters, number of words in subcategory clusters, and number of switches between subcategories were analyzed to provide a refined analysis of strategic processing. Compared with controls, children with PKU generated significantly fewer words and made significantly fewer switches between subcategories in the food/drink trial and the phonemic fluency condition. Number of switches was associated with number of words generated in these tasks. In addition, a significant interaction between age and group in number of switches for the food/drink trial reflected a greater increase in number of switches for the control than PKU group as a function of increasing age. These results suggest impairment in frontally-mediated aspects of strategic processing in children with early-treated PKU and indicate that strategic processing should be evaluated carefully as these children age.

Acknowledgments

This research was supported by the National Institute of Child Health and Human Development grant R01HD044901. Desirée A. White serves as a consultant for Merck Serono S. A.; Desirée A. White and Dorothy K. Grange serve as consultants for and receive research funding from BioMarin Pharmaceutical, Inc.; Robert D. Steiner served as a consultant for BioMarin Pharmaceutical, Inc. in the past. The authors wish to thank Suzin Blankenship, Laurie Sprietsma, and Tina Marrone for their contributions to this study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.